FDA Requests Comments on Potential Modification to Opioid Analgesic Risk Evaluation and Mitigation Strategy Read more
CME/CNE/CPE Medical Education Program Helps Physicians Integrate the FDA Mycophenolate Safety Standards to Prevent Potential Birth Defects Read more
FDA REMS Pain Management and Opioid Therapy: Persistent Knowledge Gaps Among Primary Care Providers Rockpointe Program Shows Need for More Healthcare Provider Education Read more
REMS: FDA’s Application of Statutory Factors in Determining When a REMS Is Necessary — Final Guidance Read more